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Abstract. 
 
Keratin polypeptides 8 and 18 (K8/18) are in-
termediate ﬁlament (IF) proteins that are expressed in 
glandular epithelia. Although the mechanism of keratin 
turnover is poorly understood, caspase-mediated deg-
radation of type I keratins occurs during apoptosis and 
the proteasome pathway has been indirectly implicated 
in keratin turnover based on colocalization of keratin-
ubiquitin antibody staining. Here we show that K8 and 
K18 are ubiquitinated based on cotransfection of His-
tagged ubiquitin and human K8 and/or K18 cDNAs, 
followed by puriﬁcation of ubiquitinated proteins and 
immunoblotting with keratin antibodies. Transfection 
of K8 or K18 alone yields higher levels of keratin ubiq-
uitination as compared with cotransfection of K8/18, 
likely due to stabilization of the keratin heteropolymer. 
Most of the ubiquitinated species partition with the 
noncytosolic keratin fraction. Proteasome inhibition 
stabilizes K8 and K18 turnover, and is associated with 
accumulation of phosphorylated keratins, which indi-
cates that although keratins are stable they still turn-
over. Analysis of K8 and K18 ubiquitination and degra-
dation showed that K8 phosphorylation contributes to 
its stabilization. Our results provide direct evidence for 
K8 and K18 ubiquitination, in a phosphorylation modu-
lated fashion, as a mechanism for regulating their turn-
over and suggest that other IF proteins could undergo 
similar regulation. These and other data offer a model 
that links keratin ubiquitination and hyperphosphory-
lation that, in turn, are associated with Mallory body 
deposits in a variety of liver diseases.
Key words: ubiquitination • keratins • phosphoryla-
tion • intermediate ﬁlaments • Mallory bodies
 
Introduction
 
Keratins are epithelial-specific intermediate filament (IF)
 
1
 
proteins that comprise more than 20 members (K1-K20;
Fuchs and Weber, 1994). They are subdivided into type I
(K9-K20) and type II (K1-K8) keratins (Moll et al., 1982;
Fuchs and Weber, 1994). Various keratin combinations
are expressed in an epithelial cell type–preferential man-
ner, and form noncovalent heteropolymers of a 1:1 type I
to type II ratio. For example, keratin 8 and 18 (K8/18) are
found mainly in simple-type epithelia as in the liver, pan-
creas and intestine, while K5/14 and K1/10 are found in
basal and suprabasal keratinocytes, respectively. All IF
proteins possess a central 
 
a
 
-helical rod domain and non–
 
a
 
-helical NH
 
2
 
-terminal (head) and COOH-terminal (tail)
domains. The head and tail domains manifest significant
structural heterogeneity among IF proteins as compared
with the rod domains (Fuchs and Weber, 1994), and con-
tain the sites for several posttranslational modifications in-
cluding phosphorylation and glycosylation (Omary et al.,
1998).
Keratins are highly dynamic and reorganize during vari-
ous cellular events such as mitosis and apoptosis. Al-
though keratin functions remain poorly understood, ex-
cept for their important role in helping cells cope with
stress (Fuchs and Cleveland, 1998; Ku et al., 1999), it is hy-
pothesized that filament reorganization plays an integral
role in keratin function. Potential mechanisms that are
likely involved in filament reorganization include phos-
phorylation, proteolysis, and/or interaction with non-kera-
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Abbreviations used in this paper: 
 
Ab, antibody; ALLN, N-acetyl-Leu-
Leu-norleucinal; IF, intermediate filament(s); K, keratin; MB, Mallory
bodies; Ub, ubiquitin. 
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tin proteins. In the case of K8/18, K8 serines (S) 23/73/431
and K18 S33/52 are known in vivo phosphorylation sites
(Omary et al., 1998). Proteolysis of keratins has been de-
scribed during virus infection (Zhang and Schneider, 1994)
and apoptosis (Caulin et al., 1997; Ku et al., 1997) and is
mediated by viral proteases or caspases, respectively. Deg-
radation, possibly by caspases, and abnormal keratin fila-
ments have also been described in newborn rats that are
exposed to ethanol in utero (Montes et al., 1996).
Keratin degradation via ubiquitination has also been im-
plicated although direct evidence for this is lacking. For
example, K8/18 and ubiquitin colocalize in hepatocyte cy-
toplasmic inclusions termed Mallory bodies (MB), as de-
termined by immunofluorescence staining (Lowe et al.,
1988; Ohta et al., 1988). MB inclusions are found in a vari-
ety of human liver diseases and can be induced in mice af-
ter chronic drug intoxication (Jensen and Gluud, 1994). In
addition, ubiquitin-conjugated K8 fragments, but not in-
tact K8, accumulate in colorectal carcinomas (Nishibori et
al., 1996). The significance of keratin ubiquitination in MB
inclusions is unclear but it may be associated with keratin
stabilization or, alternatively, with keratin degradation
as occurs in a number of well-studied ubiquitinated pro-
teins (Hershko and Ciechanover, 1998; Laney and Hoch-
strasser, 1999). In general, keratin turnover appears to be
a very slow process as demonstrated in cultured hepato-
cytes (Denk et al., 1987) and colonocytes (Chou et al.,
1992). However, the abundance of keratins (e.g., K8/18
make up 
 
z
 
5% of total cultured cell protein; Chou et al.,
1993) makes it difficult to appreciate subtle changes in
keratin turnover. In this report, we provide direct evi-
dence for K8/18 ubiquitination and subsequent degrada-
tion in vivo, and show that keratin phosphorylation modu-
lates this process.
 
Materials and Methods
 
Cells and Reagents
 
Cell lines (HT29 [human colon], BHK [hamster kidney]) were obtained
from the American Type Culture Collection. Antibodies (Abs) used were:
L2A1 (anti-K8/18; Chou et al., 1992), M20, and TS1 (anti-K8), DC10
(anti-K18; Neomarkers), LJ4 (anti-K8 phospho-(p)S73; Liao et al., 1997),
IB4 and 8250 (anti-K18 pS33; Ku et al., 1998a), 5B3 (anti-K8 pS431; Ku
and Omary, 1997), anti-ubiquitin (Ub) Ab (Dako Corp.), 8592 (anti-K8/18;
Ku and Omary, 1997), 3055 (anti-K18 pS52; Liao et al., 1995), and Ab 4668,
which was raised against the nonphosphorylated K18 form of the peptide
used to generate Abs 8250 and IB4 (Ku et al., 1998a). Other reagents used
were: anti-His tag Ab, NiNTA™ Spin kit (Qiagen), and the proteasome in-
hibitor N-acetyl-Leu-Leu-norleucinal (ALLN; Calbiochem).
 
Cell Culture and Transfection
 
BHK cells, cotransfected with one or more of several keratin constructs
and His-tagged wild-type (WT) ubiquitin (kindly provided by Dr. Ron
Kopito, Stanford University), or HT29 cells were treated overnight with
DMSO (0.1%) or with ALLN dissolved in DMSO (270 
 
m
 
M). Cells were
then solubilized with SDS (2%)-containing sample buffer or used for im-
munoprecipitation or isolation of the ubiquitinated proteins. Transient
transfection was carried out using LipofectAMINE™ (GIBCO BRL).
The constructs used for transfection were: WT K8 and/or K18; K8 S431,
S73 or S23
 
®
 
alanine (A; Ku et al., 1997; Liao et al., 1997); and K18 S52 or
S33
 
®
 
A (Ku and Omary 1994; Ku et al., 1998a). Other K8 constructs
(L71
 
®
 
P, S73
 
®
 
D, P74
 
®
 
L) were generated with a Transformer™ mu-
tagenesis kit (CLONTECH Laboratories, Inc.). Metabolic labeling with
 
35
 
S-met/cys (100 
 
m
 
Ci/ml, 10 min) was done in RPMI 1640 medium lacking
met (note K8 and K18 do not have any cys, not shown) and containing
10% dialyzed fetal calf serum. Cells were cultured in the labeling medium
for 30 min before adding 
 
35
 
S-met/cys, then processed immediately or cul-
tured in normal medium for various chase periods.
 
Analysis of Keratins
 
Immunoprecipitates of K8, K18, or K8/18 were obtained from HT29 cells
or from transfected (
 
35
 
S-met labeled or unlabeled) BHK cells after solubi-
lization. Fractionation into cytosolic and residual pellet fractions was done
by three cycles of freeze-thawing of transfected cells in PBS containing 5
mM EDTA followed by centrifugation. Alternatively, ubiquitinated pro-
teins were isolated using the NiNTA™ kit as recommended by the sup-
plier (the presence of NP-40 interfered with binding to the nickel beads,
not shown) followed by separation by SDS-PAGE, Coomassie staining
and fluorography when relevant. Total cell lysates, cytosolic or remaining
pellet fractions, NiNTA-isolated proteins, or immunoprecipitates were
also analyzed by immunoblotting then visualization of the blotted proteins
using enhanced chemiluminescence. Densitometry to quantify 
 
35
 
S-ker-
atins was done with a Bio-Rad Fluor-S MultiImager system.
 
Results
 
K8 and K18 Are Ubiquitinated In Vivo
 
We tested the effect of proteasome inhibition on keratins
in cultured HT29 cells (Fig. 1 A). ALLN increased the
level of detectable ubiquitinated proteins (lane 4), and
generated K8 (lane 6) and K18 (lane 8) ladders. However,
the extent of ladder formation was minimal and required
significant over-exposure for visualization, and several
anti-Ub Abs did not bind K8/18 immunoprecipitates likely
due to inability to precipitate the ubiquitinated keratins
(not shown). This led us to test keratin ubiquitination in a
cell transfection system that included cotransfection of
His-tagged Ub with K8 and/or K18 to allow isolation of
the ubiquitinated proteins. Proteasome inhibition of kera-
tin-transfected BHK cells markedly increased the ability
to detect ubiquitinated proteins as determined by blotting
of total cell lysates or cell fractions that are collected with
a Ni column in order to isolate His-tagged ubiquitinated
proteins (Fig. 1 B). Confirmation of K8/18 ubiquitination
was obtained by immunoblotting the Ni column–purified
samples with K8- or K18-specific Abs (Fig. 1 C). Exposure
of transfected cells to ALLN increased the singly ubiquiti-
nated K8 and K18 species, while the level of ubiquitinated
K8 and K18 was significantly less in cotransfected K8/18
cells as compared with single keratin-transfected cells. The
K8 and K18 antibodies did not recognize any multiply-
ubiquitinated keratins which may be due to the Ni column
binding efficiency to single ubiquitinated species. Overall,
these data indicate that K8 and K18 can be ubiquitinated
in vivo, with enhanced levels of ubiquitinated species upon
proteasome inhibition or upon expression of single ker-
atins rather coexpression of type I and type II keratins.
To assess if keratin ubiquitination plays a role in keratin
degradation, we compared the turnover of 
 
35
 
S-methionine
pulse-labeled K8, K18, and K8/18 in transfected BHK cells
in the presence or absence of ALLN (Fig. 2 A). After a 10-
min pulse, ALLN increased the level of detectable K8
(lane 1 vs 2) and K8/18 (lane 9 vs 10) but had no effect on
singly expressed K18 (lane 5 vs 6). The effect of ALLN
was not appreciable after 4 h of chase for singly trans-
fected K8 or K18 due to rapid degradation but was clearly
evident for cotransfected K8/18 due to the increased sta-
bility of the cotransfected keratins (Fig. 2 A, lanes 9–12). 
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K18 fragments (p29 and p23) also form upon K18 transfec-
tion of BHK cells, as detected by fluorography after a 4-h
chase (lane 12), due to caspase-mediated cleavage (Ku
et al., 1997) as newly synthesized proteins accumulate.
Hence, proteasome inhibition stabilizes newly synthesized
K8 or K8/18, but not K18 alone, which supports keratin
ubiquitination being an intermediate step for keratin deg-
radation.
We also examined the solubility of ubiquitinated species
in transfected BHK cells. The detergent-free cytosolic ker-
atin pool under these conditions is undetectable (Fig. 2 C,
lanes 1, 4, and 7), and all the ubiquitinated keratin species
are present in the remaining insoluble pellet (Fig. 2 C,
compare lanes P with T). However, the cytosolic pool did
contain ubiquitinated proteins as exemplified in lane C of
the NiNTA-purified proteins isolated from cells trans-
fected with K8 (Fig. 2 B), K8/18 or K18 (not shown but
very similar profile to that shown in Fig. 2 B). Hence, the
ubiquitinated keratin species are preferentially noncyto-
solic.
Figure 1. In vivo ubiquitination of K8 and K18.
BHK cells, cotransfected with the indicated kera-
tin(s) and His-Ub, or HT29 cells were treated over-
night with DMSO (0.1%) or with an equal volume
of ALLN (in DMSO). Total lysates were prepared
by solubilizing the cell pellets in sample buffer, and
His-ubiquitinated proteins from keratin-transfected
BHK cells were purified using a Ni column after cell
solubilization in 8-M urea. Total lysates and Ni col-
umn–purified samples were separated by SDS-
PAGE then stained with Coomassie blue, or were
immunoblotted with antibodies to Ub (His), K8, or
K18. Asterisks in A highlight bands that likely cor-
respond to ubiquitinated K8 or K18 in ALLN-
treated HT29 cells. Asterisks in C represent species
that likely correspond to ubiquitinated K8/18 frag-
ments and/or unmodified K8/18 that is part of the
keratin tetramer.
 
Figure 2.
 
Stabilization of transfected keratins by proteasome in-
hibition and partitioning of ubiquinated keratins with the insolu-
ble pool. (A) BHK cells were transfected with K8 and/or K18.
After 36 h, transfected cells were incubated overnight with
DMSO or ALLN as in Fig. 1, then labeled with 
 
35
 
S-met (10 min)
followed by immediate harvesting or chasing for 4 h. K8, K18 or
K8/18 were precipitated with Abs TS1, DC10, and L2A1, respec-
tively. Immunoprecipitates were analyzed by SDS-PAGE then
Coomassie staining and fluorography, or were blotted with anti-
bodies to K8 or K18. Due to significant K8 and K18 degradation
and their low overall levels when transfected alone, their immu-
noprecipitates were visualized by blotting rather than Coomassie
staining. Asterisks (lane 1) correspond to induced K18 (transfec-
tion of K8 likely induces endogenous hamster K18 expression,
see also Fig. 4 C) and to K8 and/or K18 degradation products. (B
and C) BHK cells were transfected with K8 and/or K18 and with
His-Ub followed by isolation of a cytosolic (C), remaining pellet
(P) and total cell lysates (T). Ubiquitinated proteins (NiNTA-
purified) were also isolated from each of these fractions followed
blotting with anti-K8 and anti-K18 Abs. 
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Phosphorylated Keratins Accumulate upon Proteasome 
Inhibition and Are Less Ubiquitinated
 
Given that several proteins undergo Ub-mediated degra-
dation in a phosphorylation-dependent fashion, we exam-
ined the effect of proteasome inhibition on keratin phos-
phorylation in HT29 cells and in transfected BHK cells.
HT29 cells, cultured with ALLN, accumulated phosphory-
lated keratins including K8 pS73, K8 pS431, and K18 pS52,
but not K18 pS33 (Fig. 3 A). This suggested that keratin
phosphorylation may be a protective mechanism against
keratin degradation or, alternatively, that it may promote
keratin degradation. To distinguish between these two
possibilities, we compared the phospho- and total-keratin
ubiquitinated species in BHK cells cotransfected with His-
Ub and K8, K18, or K8/18 using epitope-specific anti-
phosphokeratin antibodies. Ubiquitinated fractions of K8
pS73/pS431 and K18 pS52 were easily detected, while
ubiquitinated K18 pS33 was barely detected (Fig. 3, B and
C). However, the relative stoichiometries of ubiquitinated
K8 pS73/431 were significantly less than that of total ubiq-
uitinated K8 (Fig. 3 B, i.e., the relative intensities of [Ub-
phospho-K8]/[total K8] from b and c are significantly less
than [total Ub-K8]/[total K8] from a). This suggests that
K8 S73/431 phosphorylation may protect against ubiquiti-
nation. The apoptotic p29 K18 fragment was detected
more efficiently upon transfection of K8/18 as compared
with transfection of K18 alone (C, blot a, lane 3 vs 4). This
may be due to more overall caspase cleavage and less
overall K18 ubiquitination when K18 is stabilized by K8,
as compared with K18 expression alone. The minimal K18
 
S33 phosphorylation in the ubiquitinated K18 fraction sug-
gests that K18 S33 phosphorylation may serve a protective
role in modulating K18 ubiquitination.
 
Mutation of Keratin Phosphorylation Sites Increases 
Keratin Ubiquitination and Turnover
 
Given the results of Fig. 3, which suggested that keratin
phosphorylation may play a role in modulating keratin
turnover, we tested the effect of mutating K8/18 phosphor-
ylation sites on the yield of ubiquitinated keratins in
transfected cells. Mutation of any of the three K8 phos-
phorylation sites (S23/73/431) increased the yield of ubiq-
uitinated K8 (Fig. 4 A) which is consistent with the results
of Fig. 3 B. The association of K8 ubiquitination with its
turnover was then assessed by comparing the turnover of
WT versus phosphorylation-mutant K8. As shown in Fig. 4
C, 14% of 
 
35
 
S-met labeled WT K8 degrades after a 1-h
chase (lane 1 vs 2) while 52% of K8 S73
 
®
 
A degrades after
the same chase period (lane 3 vs 4). Substitution of an as-
partate, which can mimic a phosphate, provided partial
protection from degradation in that 26% of K8 was de-
graded.
We also examined K8 residues that are proximal to K8
S73, namely L71 and P74 of the sequence 
 
69
 
QS
 
L
 
LS
 
P
 
L,
which are conserved in all type II keratins. Mutations of
the corresponding K8 L71 and P74 in epidermal keratins
(K1 L160
 
®
 
P and K5 P156
 
®
 
L) have been described in pa-
tients with keratin-related skin diseases (Chipev et al.,
1992; Muller et al., 1998). K8 L71
 
®
 
P (
 
69
 
QS
 
P
 
LSPL) gener-
ates a K8 S70 potential phosphorylation site that indeed
Figure 3. Keratin phosphor-
ylation in HT29 and trans-
fected BHK cells. (A) HT29
cells were incubated with
DMSO or ALLN as in Fig. 1
followed by immunoprecipi-
tation of K8/18 using Ab
L2A1. Precipitates were
blotted with site-specific
phosphokeratin antibodies:
K18 pS33 (Ab 8250), K18
pS52 (Ab 3055), K8 pS73
(Ab LJ4), K8 pS431 (Ab
5B3). Note that ALLN treat-
ment generates the previ-
ously described hyperphos-
phorylated form of K8 (due
to pS73), termed hK8 (Liao
et al., 1997), that is seen as a
faint band just above K8
(lane 2) and is recognized by
Ab LJ4 (lane 8). (B and C)
BHK cells were cotrans-
fected with His-Ub and vec-
tor alone (labeled as none),
K8 and/or K18. After 2 d,
cells were solubilized directly
in sample buffer or used to purify Ub-conjugated proteins with a Ni column. The total lysate and the Ni column–purified proteins were
blotted with anti-K8 (B) or anti-K18 (C) antibodies. The bands enclosed within the dotted lines (C, blot b) are nonspecific since they are
also observed in vector alone–transfected cells. The antibodies used were: M20 (total K8 pool), LJ4 (K8 pS73), 5B3 (K8 pS431), DC10
(total K18 pool), 3055 (K18 pS52), IB4 (K18 pS33), and 4668 (K18 S33, i.e., the nonphosphorylated epitope). Immunoblotting with Ab
8250, which recognizes K18 pS33 also gave a similar result to that in Fig. 3 C, c (not shown). 
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becomes phosphorylated, while K8 P74
 
®
 
L (
 
69
 
QSLLS
 
L
 
L)
abolishes K8 S73 phosphorylation (not shown). Mutation
of K8 S73
 
®
 
A/D or P74
 
®
 
L (i.e., conditions that decrease
K8 phosphorylation in proximity to S73) increased K8
ubiquitination (Fig. 4 B) and, in contrast, mutation of K8
L71
 
®
 
P (which increases K8 phosphorylation, not shown)
decreased K8 ubiquitination. Taken together, these data
indicate that K8 phosphorylation protects against ubiquiti-
nation and subsequent degradation.
In contrast to the apparent involvement of K8 phosphor-
ylation with its ubiquitination, mutation of K18 ser52/33
did not alter the levels of Ni column isolated K18 in His-
Ub transfected BHK cells (not shown). In addition, the
turnover of 
 
35
 
S-met labeled K18 S33
 
®
 
A/D is not signifi-
cantly different as compared with 
 
35
 
S-met labeled WT K18
(Fig. 4 C).
 
Discussion
 
The overall findings of this study are: (a) K8 and K18 can
be ubiquitinated in vivo, particularly when each keratin
is expressed individually (Fig. 1), and the ubiquitinated
species are associated with the noncytosolic fraction (Fig.
2, B and C). (b) Keratin ubiquitination is associated with
 
its degradation since proteasome inhibition also inhibits
keratin degradation (Fig. 2). Although keratins are highly
stable proteins, ALLN inhibition of keratin degradation
despite coexpression of types I and II keratins (Fig. 2 A)
suggests that keratin turnover by ubiquitination is a phys-
iologic process that is likely difficult to appreciate due to
its rapidity and to keratin abundance. (c) Proteasome in-
hibition results in accumulation of phosphorylated K8
and K18 with hyper- or neo-phosphorylation of most
(i.e., K8 S431/73, K18 S52) but not all sites (e.g., K18 S33;
see Fig. 3). In the case of K8, its phosphorylation protects
from, but does not prevent, keratin ubiquitination (Fig.
4). This protection does not appear to be site specific,
and involves K8 S23/73/431 which undergo phosphoryla-
tion during several biologic contexts (Omary et al., 1998).
In the case of K18, an association of its phosphorylation
with ubiquitination remains unclear. Although Ub-medi-
ated degradation of many proteins is facilitated by phos-
phorylation (Hershko and Ciechanover, 1998; Laney and
Hochstrasser, 1999), several proteins are protected by
phosphorylation as noted for p53 (Chehab et al., 1999),
c-fos (Okazaki and Sagata, 1995), c-Jun (Musti et al.,
1997), and K8 (shown herein). It is, however, possible
that other keratin phosphorylation sites may turn out
to serve a degradation-promoting role. Similar modes
of ubiquitination and degradation, in phosphorylation-
dependent or -independent fashions, are likely to involve
other IF proteins.
Ubiquitination and degradation may be coupled or un-
coupled since degradation requires an active proteasome.
Examples of uncoupling that apply to most if not all IF
proteins are the codecoration of Ub and IF proteins as re-
ported in several cytoplasmic deposits in association with a
number of diseases (e.g., Lowe et al., 1988; Ohta et al.,
1988; Akamatsu et al., 1995). One potential explanation
is that the inclusion-associated diseases result in states
whereby the proteasome capacity is exceeded (Johnston et
al., 1998) or inhibited, with subsequent accumulation of
ubiquitinated proteins within aggresomes. In the case of
MB, which stain with antibodies to keratins and Ub, kera-
tin hyperphosphorylation (Stumptner et al., 2000) and in-
creased K8 and K18 synthesis (Cadrin et al., 1995; Hutter
et al., 1993) occur as an early event during their formation.
These data suggest a model whereby liver injury induces
increased keratin synthesis and phosphorylation. Increased
keratin synthesis, particularly if unbalanced between types
I and II keratins, may then predispose to keratin ubiquiti-
nation. Keratin hyperphosphorylation in vivo protects
against liver injury (Ku et al., 1998b) and as reported herein
may also protect (in the case of K8) but not prevent kera-
tin ubiquitination. Ubiquitinated and hyperphosphory-
lated keratins may then accumulate if the proteasome ca-
pacity is overloaded or suppressed.
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Figure 4. Accumulation and turnover of ubiquitinated K8 upon
mutation of its phosphorylation sites. (A and B) The indicated
K8 constructs and His-Ub were transfected into BHK cells. Cells
were then divided into two equivalent fractions, one of which was
used to prepare a total lysate and the second was used to isolate
ubiquitinated proteins for immunoblotting with anti-K8 Ab. The
multiple bands above K8 (lanes 3, 8, and 9) represent hyperphos-
phorylated and/or ubiquitinated K8. (C) BHK cells were trans-
fected with the indicated K8 (lanes 1–6) or K18 (lanes 7–12) con-
structs, labeled with 35S-met for 10 min (after incubating with
ALLN for 6 h), then chased for 60 min (K8) or 40 min (K18) fol-
lowed by immunoprecipitation as described in Fig. 2. Equal
amounts of the K8 and K18 precipitates were loaded as con-
firmed by blotting with anti-K8 or anti-K18 antibodies. K8 levels
(see text) were quantified by densitometric scanning of the radio-
labeled K8 bands after fluorography and exposure to x-ray film.
Note that transfection with K8 stabilizes the endogenous low lev-
els of BHK hamster K18 (lanes 1–6). The band indicated by an
asterisk in lanes 7–12 likely corresponds to hamster K18. 
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